Back
ESC Premium Access

Teneligliptin attenuated AngII-induced cardiac hypertrophy by inhibiting Nox4-HDAC4 axis

Session: Poster Session 3 - Cardiac remodelling
Topic: Cardiac Hypertrophy
Speaker: Mr K. Okabe (Fukuoka, JP)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Mr Kosuke Okabe

Fukuoka Red Cross Hospital, Fukuoka (Japan)
0 follower

9 more presentations in this session

Specific MMP-9 and MMP-2 inhibition by novel MMP antibody attenuates LV remodeling secondary to volume overload

Speaker: Mrs L. Cohen (Tel Aviv, IL)

Access
Abstract
Like
Thumbnail

SLMAP expression is altered during cardiac remodeling and it regulates cardiomyocyte response to adrenergic stimuli

Speaker: Associate Professor M. Nader (Abu Dhabi, AE)

Access
Abstract
Like
Thumbnail

Anti-inflammatory factor Del-1 protects from angiotensin II-induced hypertension and cardiovascular remodelling

Speaker: Doctor I. Kopaliani (Dresden, DE)

Access
Abstract
Like
Thumbnail

Cardiac nuclear high-mobility group box 1 attenuates angiotensin II induced pathological cardiac hypertrophy by inhibiting DNA damage response pathway

Speaker: Doctor T. Takahashi (Yamagata, JP)

Access
Abstract
Like
Thumbnail

Loss of akap1 exacerbates pressure overload-induced cardiac hypertrophy and failure

Speaker: Mr N. Boccella (Napoly, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Cardiac remodelling

Speakers: Mr K. Okabe, Mrs L. Cohen, Associate Professor M. Nader, Doctor I. Kopaliani, Doctor T. Takahashi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources